Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis and HIV: latest news

Hepatitis and HIV resources

  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1
  • How hepatitis C is passed on

    When the blood of a person who has hepatitis C enters the bloodstream of another person, that person could get hepatitis C.Tiny and unseen traces...

    From: The basics

    Information level Level 1
  • Liver function tests

    People living with HIV should have regular blood tests to monitor liver function.The liver plays an important role in processing drugs used to treat HIV...

    From: Factsheets

    Information level Level 2
  • Other health issues

    As you get older, it’s even more important to regularly attend clinic appointments and stay in touch with your healthcare providers. Your HIV clinic appointments will include...

    From: Booklets

    Information level Level 2
  • Treatment for people with HIV and HCV co-infection

    In the UK, standards for HIV treatment and care are set and monitored by the British HIV Association (BHIVA), the professional association for HIV doctors and other healthcare...

    From: Booklets

    Information level Level 2
  • HIV & hepatitis

    This booklet gives information for people with HIV who also have hepatitis A, hepatitis B or hepatitis C....

    From: Booklets

    Information level Level 2
  • Hepatitis B and HIV

    Hepatitis B is a blood-borne infection that is transmitted in some of the same ways as HIV.Hepatitis B can be prevented...

    From: Factsheets

    Information level Level 2
  • Hepatitis C and HIV

    Hepatitis C is a blood-borne infection that is transmitted in some of the same ways as HIV.Over time untreated hepatitis C...

    From: Factsheets

    Information level Level 2
  • Fatty liver disease and HIV

    Fatty liver disease occurs when fat builds up in liver cells. A healthy diet and exercise can reduce your risk of fatty liver disease. There are currently no good treatments...

    From: Factsheets

    Information level Level 2
  • Other tests

    Blood pressure is the force that the beating heart causes in the arteries, veins, and blood vessels that carry blood around the body. Blood pressure is measured...

    From: Booklets

    Information level Level 2
  • How hepatitis C is passed on during sex

    Hepatitis C can be passed on during sex that could lead to contact with semen, rectal mucus or blood.Many gay men with HIV have picked...

    From: The basics

    Information level Level 1
  • The liver

    The liver plays an important role in how the body processes anti-HIV drugs.Hepatitis means inflammation of the liver and is relatively common in people with...

    From: Factsheets

    Information level Level 2
  • Hepatitis and other liver disease

    The liver has many important functions in the body. For people with HIV, it plays a vital role in processing the drugs used to treat HIV. Some...

    From: Booklets

    Information level Level 2
  • HIV and hepatitis co-infection

    Hepatitis is a viral infection that affects your liver. Some types – hepatitis B and C – can cause long-term, serious health problems. Many people with HIV...

    From: Booklets

    Information level Level 2

Hepatitis and HIV features

Hepatitis and HIV in your own words

Hepatitis and HIV news from aidsmap

More news

Hepatitis and HIV news selected from other sources

  • Expert working group recommends bold action to eliminate hepatitis C in Scotland; now we need a national elimination strategy

    A new report published by Health Protection Scotland sets out national recommendations for improvements to case finding and access to care which would accelerate Scotland’s efforts to eliminate hepatitis C. The Hepatitis C Trust calls on the Scottish Government to set out a clear timeline and process for developing and releasing a national elimination strategy for hepatitis C, in order to facilitate implementation of the recommendations contained in the recent Health Protection Scotland report.

    19 February 2019 | Hepatitis C Trust
  • Trial launched to study HIV-to-HIV liver transplant outcomes

    The new study will track the success of 80 liver transplants to HIV-positive people. Half of the livers will come from deceased HIV-positive donors and the other half will come from deceased HIV-negative donors.

    16 February 2019 | UPI
  • Low testosterone persists after HCV clearance

    Low levels of free testosterone are common among men with chronic hepatitis C infection following SVR and persist after HCV clearance, according to findings from a prospective, longitudinal cohort study.

    12 February 2019 | Healio
  • England: Countdown to hep C eradication

    NHS England’s target date to eliminate hepatitis C is now just six years away. DDN hears what progress has been made, and what’s left to achieve, at the LJWG on Substance Use and Hepatitis C annual conference.

    05 February 2019 | Drink & Drug News
  • UK court dismisses AbbVie's legal challenge against the NHS

    The High Court has dismissed a legal challenge by US pharmaceutical firm AbbVie against the National Health Service (NHS) England's procurement deal for drugs to treat and cure hepatitis C. The decision means that the plan to eliminate the virus in England remains on track.

    25 January 2019 | The Lancet (free registration required)
  • Undiagnosed HBV, HCV, HIV prevalent in newly diagnosed cancer cases

    Researchers discovered a substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis C or hepatitis B were unaware of their viral infection and many had no identifiable risk factors, according to a recently published study.

    18 January 2019 | Healio
  • Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

    When hepatitis C (HCV) is acquired in patients with HIV infection, CD4 T-cell counts temporarily decline after HCV seroconversion, regardless of the duration of HIV or whether the patient is on combination antiretroviral therapy (cART), according to study findings published in AIDS.

    09 January 2019 | Infectious Disease Advisor
  • Hep C Infection May Be on the Rise Among Men Using PrEP

    The incidence of sexually acquired hepatitis C virus (HCV) infections appears to be rising among men who have sex with men (MSM) and use pre-exposure prophylaxis (PrEP) against HIV, U.S. researchers report.

    09 January 2019 | Medscape (requires free registration)
  • Advanced fibrosis found in one-third of patients with HIV/HBV coinfection

    Researchers observed significant fibrosis in more than one-third of patients with hepatitis B and HIV coinfection undergoing long-term combination antiretroviral therapy with viral suppression, according to a study published in American Journal of Gastroenterology.

    03 January 2019 | Healio
  • CD4 Cells Decline After People With HIV Contract Hepatitis C

    This holds true regardless of how long they’ve had HIV or whether they’re on antiretrovirals.

    03 January 2019 | Poz
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.